Denali Therapeutics Inc.
← Back to DNLI Overview

Denali Therapeutics Inc. (DNLI)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-5.63

Financial Fundamentals

DNLIQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2016-03-31-1.59
2016-06-30-1.59
2016-09-30-1.19
2016-12-31-2.50
2017-03-31-2.27
2017-06-30-16.53
2017-09-30-20.23
2017-12-31-5.25
2018-03-31-18.62
2018-06-30-6.47
2018-09-30-14.27
2018-12-316.28
2019-03-31-14.69
2019-06-30-8.52
2019-09-30-7.94
2019-12-31-7.70
2020-03-31-7.90
2020-06-30-10.88
2020-09-30-16.54
2020-12-3110.27
2021-03-31-24.61
2021-06-30-39.19
2021-09-30-18.15
2021-12-31-18.10
2022-03-31-15.13
2022-06-30-15.33
2022-09-30-9.17
2022-12-31-9.36
2023-03-31-7.16
2023-06-305.51
2023-09-30-7.15
2023-12-31-6.21
2024-03-31-7.54
2024-06-30-9.38
2024-09-30-11.51
2024-12-31-7.55
2025-03-31-4.38
2025-06-30-4.83
2025-09-30-4.93
2025-12-31-5.63

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.